secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiNK Therapeutics, Inc. (INKT)
CIK:        0001840229
Form:       8-K
Filed at:   2024-02-14T23:59:59+00:00
Accession:  0000950170-24-014944
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

MiNK Therapeutics issues up to $5.0M convertible promissory note to Agenus at 2% interest
--------------------------------------------------------------------------------

- Principal amount up to $5.0M; interest rate 2% per annum, accruing but payable upon conversion or maturity.
- Demand repayment on or after Jan 1, 2026; optional conversion into equity upon qualified financing at Agenus's election.
- Funds may be drawn in increments with Agenus's consent; advances may include payments made by Agenus on Company's behalf.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840229/000095017024014944/0000950170-24-014944-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840229/000095017024014944/inkt-20240212.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-014944

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer